Literature DB >> 8217445

Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.

I S Anand1, Y Chandrashekhar, R Ferrari, P A Poole-Wilson, P C Harris.   

Abstract

BACKGROUND: Patients with chronic severe anaemia often retain salt and water. Fluid retention in these patients is not caused by heart failure and the exact mechanisms remain unclear. This study was designed to examine some of the possible mechanisms. METHODS AND
RESULTS: Haemodynamic variables, body fluid compartments, renal function, and plasma hormones were measured in four patients with oedema caused by chronic severe anaemia (mean (SE) haematocrit 13 (1.7)) who had never received any treatment. Cardiac output was increased (6.1 (0.6) l/min/m2) and right atrial (7.8 (1) mm Hg), mean pulmonary arterial (20.5 (2.0) mm Hg), and mean pulmonary arterial wedge (13 (2.7) mm Hg) pressures were slightly increased. The mean systemic arterial pressure (81 (1.3) mm Hg) and systemic vascular resistance (12.3 (1.1) mm Hg x min x m2/l were low. There were significant increases in total body water (+14%), extracellular volume (+32%), plasma volume (+70%), and total body exchangeable sodium (+30%). Renal blood flow was moderately decreased (-46%) and the glomerular filtration rate was slightly reduced (-24%). There were significant increases in plasma noradrenaline (2.1-fold), renin activity (15-fold), aldosterone (3.2-fold), growth hormone (6.3-fold), and atrial natriuretic peptide (12-fold).
CONCLUSION: In patients with oedema caused by chronic severe anaemia there is retention of salt and water, reduction of renal blood flow and glomerular filtration rate, and neurohormonal activation similar to that seen in patients with oedema caused by myocardial disease. However, unlike patients with myocardial disease, patients with anaemia have a high cardiac output and a low systemic vascular resistance and blood pressure. It is suggested that the low concentration of haemoglobin in patients with anaemia causes a reduced inhibition of basal endothelium-derived relaxing factor activity and leads to generalised vasodilatation. The consequent low blood pressure may be the stimulus for neurohormonal activation and salt and water retention.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217445      PMCID: PMC1025332          DOI: 10.1136/hrt.70.4.357

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  30 in total

1.  The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor.

Authors:  W Martin; J A Smith; D G White
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

Review 2.  Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin.

Authors:  F Murad; C K Mittal; W P Arnold; S Katsuki; H Kimura
Journal:  Adv Cyclic Nucleotide Res       Date:  1978

3.  Hemoglobin solution in the treatment of hemorrhagic shock.

Authors:  C J Hauser; W C Shoemaker
Journal:  Crit Care Med       Date:  1982-04       Impact factor: 7.598

4.  Comparison of cardiorespiratory effects of crystalline hemoglobin, whole blood, albumin, and Ringer's lactate in the resuscitation of hemorrhagic shock in dogs.

Authors:  J E Nees; C J Hauser; C Shippy; D State; W C Shoemaker
Journal:  Surgery       Date:  1978-06       Impact factor: 3.982

5.  Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics.

Authors:  S H Kubo; M Clark; J H Laragh; J S Borer; R J Cody
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

6.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.

Authors:  W Martin; G M Villani; D Jothianandan; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

7.  Catecholamines in adult iron deficiency patients.

Authors:  A Wagner; N Fortier; A Giroux; J Lukes; L M Snyder
Journal:  Experientia       Date:  1979-05-15

8.  Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

Authors:  J Bayliss; M Norell; R Canepa-Anson; G Sutton; P Poole-Wilson
Journal:  Br Heart J       Date:  1987-01

9.  Left ventricular function in chronic anemia: evidence of noncatecholamine positive inotropic factor in the serum.

Authors:  F Florenzano; G Diaz; C Regonesi; E Escobar
Journal:  Am J Cardiol       Date:  1984-09-01       Impact factor: 2.778

10.  Effect of hematocrit reduction on hormonal and metabolic responses to exercise.

Authors:  D H Wasserman; H Lavina; A Lickley; M Vranic
Journal:  J Appl Physiol (1985)       Date:  1985-04
View more
  57 in total

1.  Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients.

Authors:  Yuya Matsue; Akihiko Matsumura; Masami Abe; Maki Ono; Mie Seya; Tomofumi Nakamura; Ryota Iwatsuka; Akira Mizukami; Masahiko Setoguchi; Wataru Nagahori; Masakazu Ohno; Makoto Suzuki; Yuji Hashimoto
Journal:  Heart Vessels       Date:  2011-12-10       Impact factor: 2.037

2.  In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty.

Authors:  Cihan Dündar; Vecih Oduncu; Ayhan Erkol; Ali Cevat Tanalp; Dicle Sırma; Ali Karagöz; Can Yücel Karabay; Alev Kılıçgedik; Selçuk Pala; Kürşat Tigen; Akın Izgi; Cevat Kırma
Journal:  Clin Res Cardiol       Date:  2011-09-20       Impact factor: 5.460

Review 3.  Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

Authors:  David M Charytan; Steven Fishbane; Jolanta Malyszko; Peter A McCullough; David Goldsmith
Journal:  Am J Kidney Dis       Date:  2015-02-26       Impact factor: 8.860

4.  Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis.

Authors:  R Ferrari; I S Anand; C Ceconi; F De Giuli; P A Poole-Wilson; P Harris
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

5.  Introduction: anemia in heart failure.

Authors:  Inder Anand
Journal:  Heart Fail Rev       Date:  2008-03-29       Impact factor: 4.214

Review 6.  Epidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndrome.

Authors:  Wasiu A Olowu
Journal:  World J Nephrol       Date:  2012-02-06

7.  The prognostic value of anemia in patients with diastolic heart failure.

Authors:  Faramarz Tehrani; Anita Phan; Ryan Morrissey; Christopher Chien; Asim Rafique; Ernst R Schwarz
Journal:  Tex Heart Inst J       Date:  2009

Review 8.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

Review 9.  Cardiorenal syndrome: pathophysiology and potential targets for clinical management.

Authors:  Parta Hatamizadeh; Gregg C Fonarow; Matthew J Budoff; Sirous Darabian; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

10.  Managing anemia in patients with chronic heart failure: what do we know?

Authors:  Ankur Sandhu; Sandeep Soman; Michael Hudson; Anatole Besarab
Journal:  Vasc Health Risk Manag       Date:  2010-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.